Clincosm LogoSign in Get a demo

Hodgkin Lymphoma, Adult

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunogenicity of COVID-19 Vaccinations in Autologous HSCT

Not yet recruiting
  • COVID-19
  • +2 more
    • Cologne, NRW, Germany
      University Hospital of Cologne
    Oct 27, 2022

    Squamous Cell Carcinoma of Head and Neck, Cancer, Carotid Stenosis Trial in Brussels (68GaNOTA-Anti-MMR-VHH2)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +7 more
    • Brussels, Brussel, Belgium
      Uz Brussel
    Sep 2, 2022

    Hodgkin Lymphoma, Adult, Hodgkin Disease Recurrent, Hodgkin Disease Refractory Trial in United States (CD30.CAR-T, Fludarabine,

    Active, not recruiting
    • Hodgkin Lymphoma, Adult
    • +3 more
    • Duarte, California
    • +4 more
    Apr 3, 2022

    Hodgkin Lymphoma, Adult, Relapse, Refractory Hodgkin Lymphoma Trial in Tianjin (PD-1 inhibitor)

    Recruiting
    • Hodgkin Lymphoma, Adult
    • +2 more
    • PD-1 inhibitor
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Dec 14, 2021

    Hodgkin Lymphoma, Adult Trial in United States (Brentuximab vedotin, ABVD)

    Completed
    Has Results
    • Hodgkin Lymphoma, Adult
    • Brentuximab vedotin
    • ABVD
    • Duarte, California
    • +5 more
    Nov 8, 2021

    Hodgkin Lymphoma, Adult Trial in Chapel Hill (ATLCAR.CD30, Bendamustine, Fludarabine)

    No longer available
    • Hodgkin Lymphoma, Adult
    • ATLCAR.CD30
    • +2 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Dec 2, 2021

    Hodgkin Lymphoma, Adult Trial in Beijing (SHR-1210)

    Completed
    • Hodgkin Lymphoma, Adult
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Oct 29, 2021

    Hodgkin Lymphoma, Adult, Relapsed Hodgkin's Disease, Adult, Refractory Hodgkin Lymphoma Trial in Caba (Evaluation of

    Recruiting
    • Hodgkin Lymphoma, Adult
    • +2 more
    • Evaluation of therapeutical approach after ASCT
    • Caba, Argentina
      FUNDALEU
    Oct 1, 2021

    Hodgkin Lymphoma, Adult, Non-Hodgkin Lymphoma, Adult Trial in Tomsk (SPECT with 99mTc-1-thio-D-glucose)

    Completed
    • Hodgkin Lymphoma, Adult
    • Non-Hodgkin Lymphoma, Adult
    • SPECT with 99mTc-1-thio-D-glucose
    • Tomsk, Russian Federation
      TomskNRMC
    Mar 30, 2021

    Hodgkin Lymphoma, Adult, T Cell Lymphoma Trial in Barcelona (HSP-CAR30)

    Recruiting
    • Hodgkin Lymphoma, Adult
    • T Cell Lymphoma
    • HSP-CAR30
    • Barcelona, Spain
      Hospital Santa Creu i Sant Pau
    Nov 30, 2020

    Hodgkin Lymphoma, Adult Trial in Spain (Induction with Brentuximab vedotin (BV), Induction without Brentuximab Vedotin,

    Recruiting
    • Hodgkin Lymphoma, Adult
    • Induction with Brentuximab vedotin (BV)
    • +2 more
    • Oviedo, Asturias, Spain
    • +18 more
    Nov 28, 2020

    Hodgkin Lymphoma, Adult Trial in Moscow (Doxorubicin, Bleomycin, Vinblastine)

    Recruiting
    • Hodgkin Lymphoma, Adult
    • Moscow, Russian Federation
      The Federal Budget-Funded Institution National Medical Surgical
    Nov 20, 2020

    Non-interventional, Long-term Follow-up of Subjects Who

    Unknown status
    • Acute Myelogenous Leukemia (AML)
    • +3 more
    • non intervational
    • Haifa, Israel
      Rambam Medical Center
    Nov 24, 2019

    Elderly Hodgkin Lymphoma Patients Treated With Chemoradiotherapy

    Unknown status
    • Hodgkin Lymphoma, Adult
      • Dijon, France
      • +1 more
      Jun 14, 2019